Science Explorer Interactive view Map
Hospital / health system · Yichang · China

Gezhouba Central Hospital of Sinopharm

gygzbzxyy.cnROR OpenAlex
Research works
70
▲ 69% vs 2013–17
Citations
309
4.4 per fractional work
Top-10% rate
15.4%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Gezhouba Central Hospital of Sinopharm is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.46× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.84× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 4.26× its world share, 1 worksImmunology and Micro…Neuroscience: 2.92× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.35× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.06× its world share, 0 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.23× its world share, 1 worksEngineeringMaterials Science: 0.67× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.32× its world share, 0 worksPhysics and AstronomyDentistry: 1.47× its world share, 0 worksDentistryHealth Professions: 0.72× its world share, 0 worksHealth ProfessionsMedicine: 2.94× its world share, 13 worksMedicineBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.3×. Every wedge is a field page.

Which keywords describe research at Gezhouba Central Hospital of Sinopharm?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Epidemiology, Inflammation, Biomarkers, Immunotherapy, Tumor Microenvironment, Biogenesis and Regulation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 11 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 11 words, with their numbers
  1. Epidemiology3▲ 3.4×15 topics
  2. Cancer3▲ 8.2×11 topics
  3. Inflammation2▲ 4.3×13 topics
  4. Biomarkers2▲ 9.3×3 topics
  5. Immunotherapy1▲ 8.3×4 topics
  6. Tumor Microenvironment1▲ 13×5 topics
  7. Oxidative Stress1▲ 3.4×9 topics
  8. Biogenesis1▲ 27×2 topics
  9. Regulation1▲ 8.8×2 topics
  10. Anti-inflammatory1▲ 15×6 topics
  11. Chronic Kidney Disease1▲ 18×3 topics

Which research topics does Gezhouba Central Hospital of Sinopharm publish most on?

By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, MicroRNA in disease regulation and Cancer-related molecular mechanisms research.

Pancreatic and Hepatic O…1Pancreatic and Hepatic Oncology Research: 1 fractional worksPancreatitis Pathology a…1Pancreatitis Pathology and Treatment: 1 fractional worksMicroRNA in disease regu…1MicroRNA in disease regulation: 1 fractional worksCancer-related molecular…1Cancer-related molecular mechanisms research: 1 fractional worksDiabetes and associated disorders: 0 fractional worksAcute Kidney Injury Research: 0 fractional worksCircular RNAs in diseases0Circular RNAs in diseases: 0 fractional worksSepsis Diagnosis and Treatment: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksIntravenous Infusion Technology and Safety: 0 fractional works
OncologySurgeryCancer ResearchGenetics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pancreatic and Hepatic Oncology Research Oncology 1 works
  2. 2 Pancreatitis Pathology and Treatment Surgery 1 works
  3. 3 MicroRNA in disease regulation Cancer Research 1 works
  4. 4 Cancer-related molecular mechanisms research Cancer Research 1 works
  5. 5 Diabetes and associated disorders Genetics 0 works
  6. 6 Acute Kidney Injury Research Nephrology 0 works
  7. 7 Circular RNAs in diseases Molecular Biology 0 works
  8. 8 Sepsis Diagnosis and Treatment Epidemiology 0 works
  9. 9 Dermatology and Skin Diseases Dermatology 0 works
  10. 10 Intravenous Infusion Technology and Safety Biomedical Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.1%not open61.9%

World: 28% of research is openly available.

with international co-authors5.2%domestic only94.8%

World: 19% is written across borders.

How has Gezhouba Central Hospital of Sinopharm's research output changed?

Output in 2018–2022 was 69% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Yichang

All research institutions in Yichang

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.